• With worldwide prevalence of NAFLD

    is estimated at 20-30%
    in the general population.

  • NASH patients are under severe oxidative stress

    due to free fatty acids ends
    with fibrosis and finally cirrhosis .

  • 15 to 25% of NASH

    Shows rapid progress
    to fibrosis.
    ( Median time is only 4 years )

Also you can see

Some Headline about Liver

Non-alcoholic fatty liver disease (NAFLD)

is associated with obesity, abnormal glucose tolerance and dyslipidemia. It has been described as the hepatic manifestation of the metabolic syndrome.

Fatty liver (steatosis) when progress

with inflammation it becomes much risky, ends with non-alcoholic steatohepatitis (NASH).

Also more Details

Some Studies about Liver

Metabolic Syndrome

- Type 2 diabetes or impaired glucose tolerance.
- Central obesity.
- Dyslipidemia.
- Raised blood pressure.


- Nausea, loss of appetite or weight loss.
- Yellowish skin and whites of the eyes (jaundice).
- Swollen abdomen and legs (edema).
- Extreme tiredness or mental confusion.
- Weakness.

Risk Factors

- Hepatitis B & C and HIV.
- Patients under chronic medicine.
- Starvation or rapid weight loss, including following gastric bypass surgery.
- Body builders with high protein intake.
- Polycystic ovary syndrome.

Sulfad Concept

  • SULFAD is a very effective & unique phytopharmaceutical brand.
  • SULFAD is the only formula which can manage underlying causes of NASH.
  • SULFAD shows synergistic effects
    due to having 4 bioactive ingredients
0 +

Awards Win

0 K


0 %

Treatment Efficiency

0 +

Years of experience


Where to buy ?

متوفر في صيدليات النهدي
Contact Us

Have Questions?
Get in Touch!

Enter Your Mail For subscribe

Contact Us

Scroll to Top